Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Anika Therapeutics Inc. (ANIK) had Weighted-Average Shares Outstanding (Diluted) of 14.30M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$26.17M |
|
$-4.87M |
|
$11.49M |
|
$14.68M |
|
$30.45M |
|
$-4.28M |
|
$0.41M |
|
$-3.87M |
|
$-3.87M |
|
$-3.96M |
|
$-3.96M |
|
$-4.87M |
|
$-3.96M |
|
$-4.28M |
|
$-2.69M |
|
14.30M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
14.30M |
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$102.51M |
|
$40.46M |
|
$88.10M |
|
$190.60M |
|
$17.90M |
|
-- |
|
$24.31M |
|
$42.21M |
|
$148.40M |
|
$138.69M |
|
$148.40M |
|
14.34M |
|
| Cash Flow Statement Financials | |
$-0.13M |
|
$1.67M |
|
$-5.44M |
|
$57.16M |
|
$53.37M |
|
$-3.79M |
|
$2.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.10% |
|
-16.37% |
|
-16.37% |
|
-- |
|
-14.79% |
|
-18.62% |
|
$-2.95M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.54 |
|
1.19 |
|
75.62 |
|
-2.67% |
|
-2.85% |
|
-2.08% |
|
-2.67% |
|
$10.35 |
|
$-0.21 |
|
$-0.01 |
|